Literature DB >> 21449247

Measurement equivalence/invariance of the abusive supervision measure across workers from Taiwan and the United States.

Changya Hu1, Tsung-Yu Wu, Yu-Hsuan Wang.   

Abstract

Growing international research interest in negative-leadership behaviors prompts the need to examine whether measures of ineffective leadership developed in the United States are equivalent across countries outside the United States. B. J. Tepper's (2000) abusive supervision measure has been used widely inside and outside the United States and merits research attention on its construct equivalence across different cultural settings. The authors conducted a series of multigroup confirmatory factor analyses to investigate the measurement equivalence of this measure across Taiwan (N = 256) and the United States (N = 389). Configural invariance was established, suggesting that both U.S. and Taiwanese samples perceive abusive supervision as a single-factor concept. Furthermore, the establishment of partial metric invariance and partial scalar invariance suggests that the abusive supervision measure is applicable to crosscultural comparisons in latent means, construct variance, construct covariances, and unstandardized path coefficients with the caution that workers from different cultures calibrate their responses differently when answering some items.

Mesh:

Year:  2011        PMID: 21449247     DOI: 10.1080/00223980.2010.542505

Source DB:  PubMed          Journal:  J Psychol        ISSN: 0022-3980


  2 in total

1.  Beyond Mistreatment at the Relationship Level: Abusive Supervision and Illegitimate Tasks.

Authors:  Maie Stein; Sylvie Vincent-Höper; Marlies Schümann; Sabine Gregersen
Journal:  Int J Environ Res Public Health       Date:  2020-04-15       Impact factor: 3.390

2.  The characteristics of patient safety culture in Japan, Taiwan and the United States.

Authors:  Shigeru Fujita; Kanako Seto; Shinya Ito; Yinghui Wu; Chiu-Chin Huang; Tomonori Hasegawa
Journal:  BMC Health Serv Res       Date:  2013-01-14       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.